首页> 外国专利> NUCLEAR SULFATED OXYSTEROL, POTENT REGULATOR OF LIPID HOMEOSTASIS, FOR THERAPY OF HYPERCHOLESTEROLEMIA, HYPERTRIGLYCERIDES, FATTY LIVER DISEASES, AND ATHEROSCLEROSIS

NUCLEAR SULFATED OXYSTEROL, POTENT REGULATOR OF LIPID HOMEOSTASIS, FOR THERAPY OF HYPERCHOLESTEROLEMIA, HYPERTRIGLYCERIDES, FATTY LIVER DISEASES, AND ATHEROSCLEROSIS

机译:核硫酸合甾醇,脂质稳态调节剂,用于高胆固醇血症,高甘油三酯,脂肪肝疾病和动脉粥样硬化的治疗

摘要

The sulfated oxysterol 5-cholesten-3β, 25-diol 3-sulphate, a nuclear cholesterol metabolite that decreases lipid biosynthesis and increases cholesterol secretion and degradation, is provided as an agent to lower intracellular and serum cholesterol and/or triglycerides, and to prevent or treat lipid accumulation-associated inflammation and conditions associated with such inflammation. Methods which involve the use of this sulfated oxysterol to treat conditions associated with high cholesterol and/or high triglycerides and/or inflammation (e.g. hypercholesterolemia, hypertriglyceridemia, non-alcoholic fatty liver diseases, atherosclerosis, etc.) are also provided.
机译:硫酸氧合甾醇5-胆甾烯-3β,25-二醇3-硫酸盐(一种减少脂质生物合成并增加胆固醇分泌和降解的核胆固醇代谢物)可作为降低细胞内和血清胆固醇和/或甘油三酸酯并预防或治疗与脂质蓄积相关的炎症以及与此类炎症相关的疾病。还提供了涉及使用该硫酸化氧固醇来治疗与高胆固醇和/或高甘油三酸酯和/或炎症(例如高胆固醇血症,高甘油三酸酯血症,非酒精性脂肪肝疾病,动脉粥样硬化等)有关的疾病的方法。

著录项

  • 公开/公告号US2010273761A1

    专利类型

  • 公开/公告日2010-10-28

    原文格式PDF

  • 申请/专利权人 SHUNLIN REN;WILLIAM M. PANDAK;

    申请/专利号US20100708803

  • 发明设计人 SHUNLIN REN;WILLIAM M. PANDAK;

    申请日2010-02-19

  • 分类号A61K31/575;C07J9;A61P3/06;A61P9/10;A61P1/16;A61P7;A61P29;C12N5;

  • 国家 US

  • 入库时间 2022-08-21 18:55:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号